RespireRx Pharmaceuticals Inc RSPI
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 471.74M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
RespireRx Pharmaceuticals Inc is engaged in the discovery, value-added development, and commercialization through partners of pharmaceuticals for the treatment of neurological and psychiatric disorders. The pipeline products of the company are dronabinol which is in a 505(b)(2) development ideas for the treatment of OSA (Obstructive Sleep Apnea), a form of sleep apnea; AMPAkines CX1739 for the treatment of bladder control and other conditions associated with spinal injury; CX717 for ADHD and CX1942 which is an injectable dosage formulation and GABAkines lead KRM-II-81 in preclinical development for treatment resistant epilepsy and non-opioid pain management.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 2
- Website
- http://www.respirerx.com
Valuation
|
Metric
|
RSPI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
RSPI
Financial Strength
|
Metric
|
RSPI
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.01 |
Interest Coverage | −3.12 |
Quick Ratio
RSPI
Profitability
|
Metric
|
RSPI
|
|---|---|
Return on Assets (Normalized) | −2,286.13% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RSPI
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|#VCCD% | LOCK|fGrXN | $127B | |||
| Moderna Inc
MRNA
| LOCK|#!g^^Qs | LOCK|^& | $87B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|GSBcXQ | LOCK|Lqf@H | $81B | |||
| argenx SE ADR
ARGX
| LOCK|w<@&nH | LOCK|&x | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|<#@h%< | LOCK|lQ | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|@@$rw^z | LOCK|cM#TK | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|z##J@zTV | LOCK|B&rf | $27B | |||
| Incyte Corp
INCY
| LOCK|wh#mnLT | LOCK|<JX | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|Qw$ZdH! | LOCK|Xk | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|j^!$L@h | LOCK|Yb$ | $14B |
United States